|
Receptors, Adrenergic, beta-3
|
D12.776.543.750.720.330.300.340.300 |
|
|
Gene Expression Regulation, Leukemic
|
G05.308.370.500 |
|
|
Gene Expression Regulation, Neoplastic
|
G05.308.370 |
|
|
Microtomy
|
E05.200.500.620.530 |
|
|
Isoaspartic Acid
|
D026581 |
[An ASPARTIC ACID residue in polypeptide chains that is linked at the beta-carboxyl group instead of at the normal, alpha-carboxyl group, polypeptide linkage. It is a result of the spontaneous decomposition of aspartic acid or ASPARAGINE residues.
] |
|
Chromaffin Granules
|
A11.284.430.214.190.875.190.190.207 |
|
|
Genes, MCC
|
G05.360.340.024.340.415.400.320 |
|
|
Adaptor Protein Complex 4
|
D12.776.543.990.150.400 |
|
|
Sertraline
|
D02.455.426.559.847.638.845.800 |
|
|
1-Naphthylamine
|
D02.455.426.559.847.638.845 |
|
|
Host vs Graft Reaction
|
G12.875.545 |
|
|
Liver Abscess, Amebic
|
C06.552.664.642 |
|
|
Liver Diseases, Parasitic
|
C06.552.664 |
|
|
Dyssomnias
|
F03.870.400 |
|
|
Sleep Wake Disorders
|
F03.870 |
|
|
Technetium Tc 99m Mertiatide
|
D12.644.456.805 |
|
|
Abetalipoproteinemia
|
C18.452.584.500.875.440.500 |
|
|
Oncogene Proteins v-myb
|
D12.776.964.700.750.903 |
|
|
Low Density Lipoprotein Receptor-Related Protein-2
|
D026561 |
[An LDL-RECEPTOR RELATED PROTEIN found in the neuroepithelium and in proximal tubular cells of the kidney. It is considered a multiligand receptor in that it binds to a variety of ligands with relatively high affinity and may function in mediating the uptake and lysosomal degradation of macromolecules such as: LIPOPROTEINS; ENDOPEPTIDASES; and PROTEASE INHIBITORS.
] |
|
Prenatal Nutritional Physiological Phenomena
|
G07.203.650.566.624 |
|
